BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 15359376)

  • 1. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
    Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
    Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alcohol on polysomnographically recorded sleep in healthy subjects.
    Feige B; Gann H; Brueck R; Hornyak M; Litsch S; Hohagen F; Riemann D
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1527-37. PubMed ID: 16930215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep electroencephalographic spectral power after withdrawal from alcohol in alcohol-dependent patients.
    Feige B; Scaal S; Hornyak M; Gann H; Riemann D
    Alcohol Clin Exp Res; 2007 Jan; 31(1):19-27. PubMed ID: 17207097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
    Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
    J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of clomethiazole on polysomnographically recorded sleep in healthy subjects.
    Gann H; Hartig K; Feige B; Brueck R; Hohagen F; Weske G; van Calker D; Riemann D
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):284-90. PubMed ID: 15864407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingestion of ethanol just prior to sleep onset impairs memory for procedural but not declarative tasks.
    Smith C; Smith D
    Sleep; 2003 Mar; 26(2):185-91. PubMed ID: 12683478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
    Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
    Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
    N Engl J Med; 1987 Sep; 317(12):722-8. PubMed ID: 3306380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.
    Aslan S; Isik E; Cosar B
    Sleep; 2002 Sep; 25(6):677-9. PubMed ID: 12224847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
    Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
    J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxification.
    Naderi-Heiden A; Frey R; Presslich O; Frottier P; Willinger U; Blasbichler T; Smetana R; Schmid D; Kasper S
    Psychiatry Res; 2005 May; 135(1):53-63. PubMed ID: 15893381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
    Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.